Mark LawlerChair, The Lancet Oncology Commission
- The Lancet Oncology Commission
- United Kingdom
About Mark Lawler
Mark Lawler is Professor of Digital Health at Queen’s University Belfast and led the Lancet Oncology European Groundshot Commission. He is a member of the board of the European Cancer Organisation, Europe’s largest multi-professional cancer organisation) and co-chairs their Special Focussed Network on the Impact of COVID-19 on Cancer and is a member of the Scientific Committee of the European Cancer Patient Coalition (Europe’s largest cancer patient advocacy organisation).
COVID-19 Recovery Health Innovation
COVID-19 Crisis, Digitalisation, Health & Well-being, Closing the Cancer Gap: Towards Better Screening and Treatment
The COVID-19 pandemic, the war in Ukraine and the cost-of-living crisis have unravelled our progress on cancer survival, but we also have a significant opportunity. The ambitious but achievable goal? An average of 70% ten-year survival rates for all European patients with cancer by 2035. Banner: Shutterstock/Rapeepat Pornsipak